Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The invertebrate glutamate-gated chloride channel receptor (GluCl) is a member of the Cys-loop family of ligand-gated ion channels, found exclusively in protostome invertebrates such as nematodes and arthropods (Wolstenholme, 2012, PubMed: 22512310). These receptors mediate fast inhibitory neurotransmission by facilitating the influx of chloride ions into neurons and muscle cells upon binding the neurotransmitter L-glutamate, resulting in membrane hyperpolarization (Cully et al., 1994, Nature: 371(6499)). GluCls play vital roles in regulating locomotion, feeding, and sensory input in parasites. They are the primary molecular targets for the macrocyclic lactone class of antiparasitic drugs, including ivermectin and moxidectin (Hibbs & Gouaux, 2011, Nature: 474(7349)). These drugs act as potent allosteric agonists, locking the channel in an open state, which leads to flaccid paralysis and the eventual death or expulsion of the parasite from the host. Because GluCls are absent in vertebrate genomes, these drugs typically exhibit a high margin of safety for the host. However, neurotoxicity can occur in hosts with compromised blood-brain barriers or specific genetic mutations in efflux transporters like MDR1 (Mealey et al., 2001, Pharmacogenetics: 11(8)).
Positive allosteric modulation and activation of the channel, leading to increased chloride conductance, membrane hyperpolarization, and flaccid paralysis of the parasite (Hibbs & Gouaux, 2011, Nature).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Invertebrate glutamate-gated chloride channel receptor (GluCl).